Relmada Therapeutics, Inc.
RLMD
$0.627
$0.0172.79%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 20.62M | 27.06M | 44.91M | 54.12M | 70.44M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 474.60K | 596.40K | 886.50K | 1.58M | 537.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 21.09M | 27.66M | 45.80M | 55.70M | 70.97M |
|
|
|||||
| Total Current Assets | 21.09M | 27.66M | 45.80M | 55.70M | 70.97M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 22.00K | 22.00K | 22.00K | 22.00K | 53.60K |
| Total Assets | 21.12M | 27.68M | 45.82M | 55.72M | 71.03M |
|
|
|||||
| Total Accounts Payable | 1.36M | 1.27M | 4.13M | 2.35M | 4.17M |
| Total Accrued Expenses | 3.77M | 3.97M | 6.16M | 5.74M | 5.36M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 5.13M | 5.23M | 10.29M | 8.09M | 9.54M |
|
|
|||||
| Total Current Liabilities | 5.13M | 5.23M | 10.29M | 8.09M | 9.54M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 32.10K | 7.50K | 4.50K | 12.60K | -- |
| Total Liabilities | 5.17M | 5.24M | 10.30M | 8.10M | 9.54M |
|
|
|||||
| Common Stock & APIC | 684.26M | 680.88M | 676.40M | 669.85M | 661.99M |
| Retained Earnings | -668.31M | -658.44M | -640.88M | -622.22M | -600.50M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 15.95M | 22.44M | 35.52M | 47.63M | 61.49M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 15.95M | 22.44M | 35.52M | 47.63M | 61.49M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 15.95M | 22.44M | 35.52M | 47.63M | 61.49M |
|
|
|||||